Mike Fay

1.9k total citations · 1 hit paper
30 papers, 1.4k citations indexed

About

Mike Fay is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Genetics. According to data from OpenAlex, Mike Fay has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Health, Toxicology and Mutagenesis, 8 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Mike Fay's work include Carcinogens and Genotoxicity Assessment (5 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Glioma Diagnosis and Treatment (4 papers). Mike Fay is often cited by papers focused on Carcinogens and Genotoxicity Assessment (5 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Glioma Diagnosis and Treatment (4 papers). Mike Fay collaborates with scholars based in United States, Australia and France. Mike Fay's co-authors include Sharon Wilbur, Henry Abadin, Julie M Klotzbach, Brian Tencza, Dianyi Yu, Shelly James, Lisa Ingerman, Joyce M. Donohue, Jewell D. Wilson and John F Risher and has published in prestigious journals such as Scientific Reports, PLoS Biology and Science Advances.

In The Last Decade

Mike Fay

29 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toxicological Profile for Chromium

2012 462 citations Sharon Wilbur, Henry Abadin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike Fay United States	15	606	328	195	135	109	30	1.4k
Archana Sharma India	16	373 0.6×	308 0.9×	78 0.4×	173 1.3×	56 0.5×	40	1.2k
Rodolphe Gilbin France	25	769 1.3×	398 1.2×	177 0.9×	68 0.5×	52 0.5×	54	1.6k
Bin Tang China	26	1.1k 1.8×	535 1.6×	123 0.6×	104 0.8×	79 0.7×	92	1.7k
K. Sera Japan	21	579 1.0×	433 1.3×	51 0.3×	75 0.6×	84 0.8×	229	2.0k
Jo Cavanagh New Zealand	22	774 1.3×	521 1.6×	206 1.1×	49 0.4×	30 0.3×	63	1.6k
Kim Jenkins Australia	9	557 0.9×	301 0.9×	321 1.6×	149 1.1×	26 0.2×	25	1.5k
Haohao Liu China	21	517 0.9×	217 0.7×	133 0.7×	73 0.5×	84 0.8×	59	1.7k
Alfina Grasso Italy	23	931 1.5×	823 2.5×	92 0.5×	81 0.6×	32 0.3×	45	1.9k
Clemens Ruepert Costa Rica	26	796 1.3×	673 2.1×	153 0.8×	81 0.6×	65 0.6×	59	1.9k

Countries citing papers authored by Mike Fay

Since Specialization

Citations

This map shows the geographic impact of Mike Fay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Fay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Fay more than expected).

Fields of papers citing papers by Mike Fay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Fay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Fay. The network helps show where Mike Fay may publish in the future.

Co-authorship network of co-authors of Mike Fay

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Fay. A scholar is included among the top collaborators of Mike Fay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Fay. Mike Fay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lobb, Richard J., Rebecca E. Lane, Sam Faulkner, et al.. (2026). Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease. Science Advances. 12(5). eadt2804–eadt2804.

Beirne, Christopher, Thomas M. Houslay, Connie J. Clark, et al.. (2021). African forest elephant movements depend on time scale and individual behavior. Scientific Reports. 11(1). 12634–12634. 21 indexed citations

Pohl, Hana R., David Wohlers, Chu-Yang Chou, et al.. (2019). Toxicological profile for glyphosate : draft for public comment. 8 indexed citations

Hong, Angela, et al.. (2018). Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance. Radiation Oncology. 13(1). 132–132. 5 indexed citations

Keith, Sam, Malcolm Williams, Mike Fay, et al.. (2017). Toxicological profile for parathion. 4 indexed citations

Taylor, Jessilynn, Mike Fay, Robert Williams, et al.. (2017). Toxicological profile for toluene. 27 indexed citations

Roney, Nickolette, Mike Fay, Chu-Yang Chou, et al.. (2016). Toxicological profile for dinitrotoluenes. 3 indexed citations

Poulsen, John R., et al.. (2016). Gabon Parks Elephant Collaring Program, 1st Annual Report Nov. 2015-Oct. 2016. 1 indexed citations

Bell, Christopher J., Nicholas Dowson, Mike Fay, et al.. (2015). Hypoxia Imaging in Gliomas With 18F-Fluoromisonidazole PET: Toward Clinical Translation. Seminars in Nuclear Medicine. 45(2). 136–150. 54 indexed citations

10.

Bell, Christopher J., Nicholas Dowson, Simon Puttick, et al.. (2015). Increasing feasibility and utility of 18 F-FDOPA PET for the management of glioma. Nuclear Medicine and Biology. 42(10). 788–795. 40 indexed citations

11.

Carroll, James, Melinda M. Protani, Mike Fay, et al.. (2014). Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese women. Medical Oncology. 31(4). 881–881. 27 indexed citations

12.

Gal, Yaniv, Stephen Rose, Pierrick Bourgeat, et al.. (2012). Automatic classification of high grade brain tumour MRI for improved resection and therapy planning. Queensland's institutional digital repository (The University of Queensland). 10. 204–11. 1 indexed citations

13.

Laperrière, Normand, James Perry, Wilson Roa, et al.. (2010). NCIC CLINICAL TRIALS GROUP (NCIC CTG) A RANDOMIZED PHASE III STUDY OF TEMOZOLOMIDE AND SHORT-COURSE RADIATION VERSUS SHORT-COURSE RADIATION ALONE IN THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME IN ELDERLY PATIENTS. 3 indexed citations

14.

Demchuk, Eugene, Patricia Ruiz, Franco Scinicariello, et al.. (2008). Computational Toxicology Methods in Public Health Practice. Toxicology Mechanisms and Methods. 18(2-3). 119–135. 11 indexed citations

15.

Abadin, Henry, Mike Fay, Julie M Klotzbach, et al.. (2008). Draft toxicological profile for chromium. 19 indexed citations

16.

Blake, Stephen, Samantha Strindberg, Bila‐Isia Inogwabini, et al.. (2007). Forest Elephant Crisis in the Congo Basin. PLoS Biology. 5(4). e111–e111. 135 indexed citations

17.

Pohl, Hana R., et al.. (2007). Chemical exposures at hazardous waste sites: Experiences from the United States and Poland. Environmental Toxicology and Pharmacology. 25(3). 283–291. 12 indexed citations

18.

Ostrowski, Stephanie R., Sharon Wilbur, Chu-Yang Chou, et al.. (1999). Agency for Toxic Substances and Disease Registry's 1997 priority list of hazardous substances. Latent effects—carcinogenesis, neurotoxicology, and developmental deficits in humans and animals. Toxicology and Industrial Health. 15(7). 602–644. 42 indexed citations

19.

Fay, Mike, William J. Brattin, & Joyce M. Donohue. (1999). Public Health Statement. Toxicology and Industrial Health. 15(8). 652–654. 47 indexed citations

20.

Roney, Nickolette, et al.. (1998). Determining Priority Hazardous Substances Related To Hazardous Waste Sites. Toxicology and Industrial Health. 14(4). 521–532. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact